Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 10/2019

Open Access 01-10-2019 | Care | Original Paper

Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review

Authors: Rogério M. Pinto, Ashley Lacombe-Duncan, Emma Sophia Kay, Kathryn R. Berringer

Published in: AIDS and Behavior | Issue 10/2019

Login to get access

Abstract

Methodological limitations in PrEP implementation studies may explain why PrEP implementation is lagging. This methodological review provides a description and critique of the methods used to identify barriers to PrEP implementation in the United States (2007–18). For each selected article, we provide: (1) research questions; (2) measures; (3) design; (4) sample (size and type); and (5) theoretical orientation. Among 79 articles which identified knowledge, attitudes, and behavioral and social/structural barriers to PrEP implementation, 51 (65%) were quantitative; 25 (32%) qualitative; and 3 (4%) were mixed-methods; overall, just one-half described a conceptual approach. About two-thirds of articles were conducted with patients and one-third with healthcare providers. Our review reveals a paucity of longitudinal, mixed-methods, and ethnographic/observational research and guiding theoretical frameworks; thus, the applicability of results are limited. We recommend that interventions aimed at PrEP implementation address barriers situated at multiple ecological domains, and thus improve PrEP access, uptake, and adherence.
Literature
1.
Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States 2010–2015; 2018.
2.
Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedPubMedCentralCrossRef
3.
Donnell D, Baeten JM, Bumpus NN, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66(3):340–8.PubMedPubMedCentralCrossRef
4.
Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedPubMedCentralCrossRef
5.
Fitch L. Tracking global oral PrEP provision: the who, what and where of oral PrEP. HIV Research for Prevention conference (HIVR4P 2018). Madrid, Spain; 2018.
6.
7.
Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP implementation through multilevel interventions: a synthesis of the literature. AIDS Behav. 2018;22(11):3681–91.PubMedPubMedCentralCrossRef
8.
Proctor EK, Landsverk J, Aarons G, Chambers D, Glisson C, Mittman B. Implementation research in mental health services: an emerging science with conceptual, methodological, and training challenges. Adm Policy Ment Health. 2009;36(1):24–34.PubMedCrossRef
9.
Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71.CrossRefPubMed
10.
Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–53.PubMedCrossRef
11.
Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018;18(1):5.PubMedPubMedCentralCrossRef
12.
Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol. 2001;30(4):668–77.PubMedCrossRef
13.
Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.PubMedPubMedCentralCrossRef
14.
Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRefPubMed
15.
FDA. FDA approves first medication to reduce HIV risk. Silver Spring; 2012.
16.
Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251–2.PubMedCrossRef
17.
Pilkington V, Hill A, Hughes S, Nwokolo N, Pozniak A. How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. J Virus Erad. 2018;4(4):215–24.PubMedPubMedCentralCrossRef
18.
Cypress BS. Rigor or reliability and validity in qualitative research: Perspectives, strategies, reconceptualization, and recommendations. Dimens Crit Care Nurs. 2017;36(4):253–63.PubMedCrossRef
19.
Strauss A, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Thousand Oaks: Sage Publications, Inc.; 1990.
20.
Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis. 2013;13:217.PubMedPubMedCentralCrossRef
21.
Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDs. 2013;27(10):553–9.PubMedCrossRef
22.
Calabrese SK, Earnshaw VA, Underhill K, Hansen NB, Dovidio JF. The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS Behav. 2014;18(2):226–40.PubMedPubMedCentralCrossRef
23.
Shaeer KM, Sherman EM, Shafiq S, Hardigan P. Exploratory survey of Florida pharmacists’ experience, knowledge, and perception of HIV pre-exposure prophylaxis. J Am Pharm Assoc. 2014;54(6):610–7.CrossRef
24.
Blumenthal J, Jain S, Krakower D, et al. Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–10.PubMedPubMedCentralCrossRef
25.
Castel AD, Feaster DJ, Tang W, et al. Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP. J Acquir Immune Defic Syndr. 2015;70(5):520–8.PubMedPubMedCentralCrossRef
26.
Krakower DS, Oldenburg CE, Mitty JA, et al. Knowledge, beliefs and practices regarding antiretroviral medications for hiv prevention: results from a survey of healthcare providers in New England. PLoS ONE. 2015;10(7):e0132398.PubMedPubMedCentralCrossRef
27.
Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903.PubMedPubMedCentralCrossRef
28.
Hakre S, Blaylock JM, Dawson P, et al. Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US air force health care providers. Med. 2016;95(32):e4511.CrossRef
29.
Krakower DS, Maloney KM, Grasso C, Melbourne K, Mayer KH. Primary care clinicians’ experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc. 2016;19(1):21165.PubMedPubMedCentralCrossRef
30.
Lelutiu-Weinberger C, Golub SA. Enhancing PrEP access for black and latino men who have sex with men. J Acquir Immune Defic Syndr. 2016;73(5):547–55.PubMedPubMedCentralCrossRef
31.
Smith DK, Mendoza MC, Stryker JE, Rose CE. PrEP Awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS ONE. 2016;11(6):e0156592.PubMedPubMedCentralCrossRef
32.
Biello KB, Oldenburg CE, Mitty JA, et al. The “safe sex” conundrum: anticipated stigma from sexual partners as a barrier to PrEP use among substance using MSM engaging in transactional sex. AIDS Behav. 2017;21(1):300–6.PubMedPubMedCentralCrossRef
33.
Blackstock OJ, Moore BA, Berkenblit GV, et al. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2017;32(1):62–70.PubMedCrossRef
34.
Doblecki-Lewis S, Liu A, Feaster D, et al. Healthcare access and PrEP continuation in San Francisco and Miami after the US PrEP Demo Project. J Acquir Immune Defic Syndr. 2017;74(5):531–8.PubMedPubMedCentralCrossRef
35.
Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.PubMedPubMedCentralCrossRef
36.
Edelman EJ, Moore BA, Calabrese SK, et al. Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS Behav. 2017;21(4):1025–33.PubMedPubMedCentralCrossRef
37.
Garfinkel DB, Alexander KA, McDonald-Mosley R, Willie TC, Decker MR. Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care. 2017;29(6):751–8.PubMedCrossRef
38.
Golub SA, Gamarel KE, Lelutiu-Weinberger C. The importance of sexual history taking for PrEP comprehension among young people of color. AIDS Behav. 2017;21(5):1315–24.PubMedPubMedCentralCrossRef
39.
Holloway IW, Tan D, Gildner JL, et al. Facilitators and barriers to pre-exposure prophylaxis willingness among young men who have sex with men who use geosocial networking applications in California. AIDS Patient Care STDs. 2017;31(12):517–27.PubMedPubMedCentralCrossRef
40.
Kalichman SC, Eaton L. Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with men. J Int AIDS Soc. 2017;20(1):21534.PubMedPubMedCentralCrossRef
41.
Kuhns LM, Hotton AL, Schneider J, Garofalo R, Fujimoto K. Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior, and peer network size. AIDS Behav. 2017;21(5):1376–82.PubMedPubMedCentralCrossRef
42.
Marks SJ, Merchant RC, Clark MA, et al. Potential healthcare insurance and provider barriers to pre-exposure prophylaxis utilization among young men who have sex with men. AIDS Patient Care STDs. 2017;31(11):470–8.PubMedPubMedCentralCrossRef
43.
Mullins TLK, Zimet G, Lally M, Xu J, Thornton S, Kahn JA. HIV care providers’ intentions to prescribe and actual prescription of pre-exposure prophylaxis to at-risk adolescents and adults. AIDS Patient Care STDs. 2017;31(12):504–16.PubMedPubMedCentralCrossRef
44.
Parisi D, Warren B, Leung SJ, et al. A multicomponent approach to evaluating a pre-exposure prophylaxis (PrEP) implementation program in five agencies in New York. J Assoc Nurses AIDS Care. 2018;29(1):10–9.PubMedCrossRef
45.
Patel RR, Mena L, Nunn A, et al. Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention. PLoS ONE. 2017;12(5):e0178737.PubMedPubMedCentralCrossRef
46.
Patel RR, Harrison LC, Patel VV, et al. HIV pre-exposure prophylaxis programs incorporating social applications can reach at-risk men who have sex with men for successful linkage to care in Missouri, USA. J Assoc Nurses AIDS Care. 2017;28(3):428–30.PubMedPubMedCentralCrossRef
47.
Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.PubMedPubMedCentralCrossRef
48.
Raifman JR, Flynn C, German D. Healthcare provider contact and pre-exposure prophylaxis in Baltimore men who have sex with men. Am J Prev Med. 2017;52(1):55–63.PubMedCrossRef
49.
Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.PubMedPubMedCentralCrossRef
50.
Blaylock JM, Hakre S, Decker CF, et al. HIV PrEP in the military: experience at a tertiary care military medical center. Mil Med. 2018;183(Suppl_1):445–9.PubMedCrossRef
51.
Broekhuis JM, Scarsi KK, Sayles HR, et al. Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV. PLoS ONE. 2018;13(11):e0207372.PubMedPubMedCentralCrossRef
52.
Calabrese SK, Earnshaw VA, Krakower DS, et al. A closer look at racism and heterosexism in medical students’ clinical decision-making related to HIV pre-exposure prophylaxis (PrEP): implications for PrEP education. AIDS Behav. 2018;22(4):1122–38.PubMedPubMedCentralCrossRef
53.
Guinness RR, Volk JE, Hurley LB, Tobias TT, Marcus JL. Low-intensity outreach to increase uptake of HIV preexposure prophylaxis among patients with sexually transmitted infections. AIDS Behav. 2018;23(2):544–7.CrossRef
54.
Hoenigl M, Jain S, Moore D, et al. Substance use and adherence to HIV preexposure prophylaxis for men who have sex with men. Emerg Infect Dis. 2018;24(12):2292.PubMedCentralCrossRef
55.
John SA, Starks TJ, Rendina HJ, Grov C, Parsons JT. Should I convince my partner to go on pre-exposure prophylaxis (PrEP)? the role of personal and relationship factors on PrEP-related social control among gay and bisexual men. AIDS Behav. 2018;22(4):1239–52.PubMedPubMedCentralCrossRef
56.
Kwakwa HA, Bessias S, Sturgis D, et al. Engaging United States black communities in HIV pre-exposure prophylaxis: analysis of a PrEP engagement cascade. J Natl Med Assoc. 2018;110(5):480–5.PubMed
57.
Lankowski AJ, Bien-Gund CH, Patel VV, Felsen UR, Silvera R, Blackstock OJ. PrEP in the real world: predictors of 6-month retention in a diverse urban cohort. AIDS Behav. 2018;23(7):1797–802.CrossRef
58.
Meyerson BE, Dinh PC Jr, Agley JD, et al. Predicting pharmacist dispensing practices and comfort related to pre-exposure prophylaxis for HIV prevention (PrEP). AIDS Behav. 2019;23(7):1925–38.PubMedCrossRefPubMedCentral
59.
Morgan E, Ryan DT, Newcomb ME, Mustanski B. High rate of discontinuation may diminish PrEP coverage among young men who have sex with men. AIDS Behav. 2018;22(11):3645–8.CrossRefPubMedPubMedCentral
60.
Mustanski B, Ryan DT, Hayford C, Phillips G 2nd, Newcomb ME, Smith JD. Geographic and individual associations with PrEP stigma: results from the RADAR cohort of diverse young men who have sex with men and transgender women. AIDS Behav. 2018;22(9):3044–56.PubMedPubMedCentralCrossRef
61.
Okoro O, Hillman L. HIV pre-exposure prophylaxis: exploring the potential for expanding the role of pharmacists in public health. J Am Pharm Assoc. 2018;58(4):412–20 (e413).CrossRef
62.
Pinto RM, Witte SS, Filippone P, Choi CJ, Walls M. Interprofessional collaboration and on-the-job training improve access to HIV testing, HIV primary care, and pre-exposure prophylaxis (PrEP). AIDS Educ Prev. 2018;30(6):474–89.PubMedPubMedCentralCrossRef
63.
Rolle CP, Rosenberg ES, Siegler AJ, et al. Challenges in translating PrEP interest into uptake in an observational study of young black MSM. J Acquir Immune Defic Syndr. 2017;76(3):250–8.PubMedPubMedCentralCrossRef
64.
Roth AM, Aumaier BL, Felsher MA, et al. An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sex Trans Dis. 2018;45(4):217–21.CrossRef
65.
Shrestha R, Altice FL, Karki P, Copenhaver MM. Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: a pilot feasibility study. AIDS Behav. 2018;22(8):2640–9.PubMedPubMedCentralCrossRef
66.
Siegler AJ, Bratcher A, Weiss KM, Mouhanna F, Ahlschlager L, Sullivan PS. Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States. Ann Epidemiol. 2018;28(12):858–64.PubMedCrossRefPubMedCentral
67.
Tekeste M, Hull S, Dovidio JF, et al. Differences in medical mistrust between black and white women: implications for patient-provider communication about PrEP. AIDS Behav. 2018;23(7):1737–48.CrossRef
68.
van Epps P, Maier M, Lund B, et al. Medication adherence in a nationwide cohort of veterans initiating pre-exposure prophylaxis (PrEP) to prevent HIV infection. J Acquir Immune Defic Syndr. 2018;77(3):272–8.PubMedCrossRef
69.
Willie TC, Stockman JK, Overstreet NM, Kershaw TS. Examining the impact of intimate partner violence type and timing on pre-exposure prophylaxis awareness, interest, and coercion. AIDS Behav. 2018;22(4):1190–200.PubMedPubMedCentralCrossRef
70.
Zhang HL, Rhea SK, Hurt CB, et al. HIV preexposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers. J Acquir Immune Defic Syndr. 2018;77(1):72–7.PubMedPubMedCentralCrossRef
71.
Hojilla CJ, Koester KA, Cohen SE, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461–9.PubMedCentralCrossRef
72.
Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS ONE. 2012;7(7):e40603.PubMedPubMedCentralCrossRef
73.
Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7:116.PubMedPubMedCentralCrossRef
74.
Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev. 2012;24(5):408–21.PubMedCrossRef
75.
Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–21.PubMedPubMedCentralCrossRef
76.
Taylor SW, Mayer KH, Elsesser SM, Mimiaga MJ, O’Cleirigh C, Safren SA. Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: perspectives of PrEP users and high-risk PrEP naïve men. AIDS Behav. 2014;18(5):871–9.CrossRefPubMedCentral
77.
Underhill K, Morrow KM, Colleran CM, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.PubMedPubMedCentralCrossRef
78.
Spector AY, Remien RH, Tross S. PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives. Subst Abuse Treat Prev Policy. 2015;10:1.PubMedPubMedCentralCrossRef
79.
Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.PubMedCrossRef
80.
Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–8.PubMedPubMedCentralCrossRef
81.
Calabrese SK, Magnus M, Mayer KH, et al. “Support your client at the space that they’re in”: HIV pre-exposure prophylaxis (PrEP) prescribers’ perspectives on PrEP-related risk compensation. AIDS Patient Care STDs. 2017;31(4):196–204.PubMedPubMedCentralCrossRef
82.
Collier KL, Colarossi LG, Sanders K. Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York City: community and provider perspectives. J Health Commun. 2017;22(3):183–9.PubMedCrossRef
83.
Golub SA, Gamarel KE, Surace A. Demographic differences in PrEP-related stereotypes: implications for implementation. AIDS Behav. 2017;21(5):1229–35.PubMedPubMedCentralCrossRef
84.
Hubach RD, Currin JM, Sanders CA, et al. Barriers to access and adoption of pre-exposure prophylaxis for the prevention of HIV among men who have sex with men (MSM) in a relatively rural state. AIDS Educ Prev. 2017;29(4):315–29.PubMedCrossRef
85.
Maloney KM, Krakower DS, Ziobro D, Rosenberger JG, Novak D, Mayer KH. Culturally competent sexual healthcare as a prerequisite for obtaining preexposure prophylaxis: findings from a qualitative study. LGBT Health. 2017;4(4):310–4.PubMedPubMedCentralCrossRef
86.
Rowniak S, Ong-Flaherty C, Selix N, Kowell N. Attitudes, beliefs, and barriers to PrEP among trans men. AIDS Educ Prev. 2017;29(4):302–14.PubMedCrossRef
87.
Wood SM, Lee S, Barg FK, Castillo M, Dowshen N. Young transgender women’s attitudes toward HIV pre-exposure prophylaxis. J Adolesc Health. 2017;60(5):549–55.PubMedPubMedCentralCrossRef
88.
Buttram ME, Kurtz SP. Representations of Pre-exposure prophylaxis, informal antiretroviral medication use for HIV prevention, and diversion on geosocial networking apps among men who have sex with men. AIDS Behav. 2018;23(7):1790–6.CrossRef
89.
Doll M, Fortenberry JD, Roseland D, McAuliff K, Wilson CM, Boyer CB. Linking HIV-negative youth to prevention services in 12 U.S. Cities: barriers and facilitators to implementing the HIV prevention continuum. J Adolesc Health. 2018;62(4):424–33.PubMedCrossRef
90.
Fletcher FE, Fisher C, Buchberg MK, et al. “Where did this [PrEP] come rrom?” African american mother/daughter perceptions related to adolescent preexposure prophylaxis (PrEP) utilization and clinical trial participation. J Empir Res Hum Res Ethics. 2018;13(2):173–84.PubMedCrossRef
91.
Franks J, Hirsch-Moverman Y, Loquere AS Jr, et al. Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT Study. AIDS Behav. 2017;22(4):1139–49.PubMedCentralCrossRef
92.
Hill BS, Patel VV, Haughton LJ, Blackstock OJ. Leveraging social media to explore black women’s perspectives on HIV pre-exposure prophylaxis. J Assoc Nurses AIDS Care. 2018;29(1):107–14.PubMedCrossRef
93.
Pawson M, Grov C. ‘It’s just an excuse to slut around’: gay and bisexual mens’ constructions of HIV pre-exposure prophylaxis (PrEP) as a social problem. Sociol Health Illn. 2018;40(8):1391–403.PubMedCrossRef
94.
Philbin MM, Parker CM, Parker RG, Wilson PA, Garcia J, Hirsch JS. Gendered social institutions and preventive healthcare seeking for black men who have sex with men: the promise of biomedical HIV prevention. Arch Sex Behav. 2018;47(7):2091–100.PubMedPubMedCentralCrossRef
95.
Rael CT, Martinez M, Giguere R, et al. Barriers and facilitators to oral PrEP use among transgender women in New York city. AIDS Behav. 2018;22(11):3627–36.PubMedPubMedCentralCrossRef
96.
Shrestha R, Karki P, Huedo-Medina TB, Copenhaver M. Intent to use preexposure prophylaxis (PrEP), HIV risk behaviors, and self-report neurocognitive symptoms by high-risk drug users: a mediation analysis. J Assoc Nurses AIDS Care. 2017;28(4):612–21.PubMedCrossRefPubMedCentral
97.
Meyers K, Rodriguez K, Brill AL, et al. Lessons for patient education around long-acting injectable PrEP: findings from a mixed-method study of Phase II trial participants. AIDS Behav. 2018;22(4):1209–16.PubMedPubMedCentralCrossRef
98.
Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men. AIDS Behav. 2018;22(11):3566–75.PubMedCrossRefPubMedCentral
99.
Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31(5):731–4.PubMedCrossRef
100.
Pellowski JA. Barriers to care for rural people living with HIV: a review of domestic research and health care models. J Assoc Nurses AIDS Care. 2013;24(5):422–37.PubMedPubMedCentralCrossRef
101.
102.
103.
Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66.CrossRefPubMed
104.
Brazil K, Ozer E, Cloutier MM, Levine R, Stryer D. From theory to practice: improving the impact of health services research. BMC Health Services Res. 2005;5:1.CrossRef
105.
106.
Hatzenbuehler ML, Link BG. Introduction to the special issue on structural stigma and health. Soc Sci Med. 2014;103:1–6.PubMedCrossRef
Metadata
Title
Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review
Authors
Rogério M. Pinto
Ashley Lacombe-Duncan
Emma Sophia Kay
Kathryn R. Berringer
Publication date
01-10-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 10/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02577-7

Other articles of this Issue 10/2019

AIDS and Behavior 10/2019 Go to the issue

Original Paper

Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load

Original Paper

Limited Knowledge and Lack of Screening for Acute HIV Infection at Primary Care Clinics in High-Prevalence Communities of New York City

Original Paper

Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California

Original Paper

Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago

Original Paper

Risk Behavior Not Associated with Self-Perception of PrEP Candidacy: Implications for Designing PrEP Services

Original Paper

Location of Pre-exposure Prophylaxis Services Across New York City Neighborhoods: Do Neighborhood Socio-demographic Characteristics and HIV Incidence Matter?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits